Company and Stock Identity

How Commure Connects to the Public Market

Company structure
Private company
Market access
No current public listing was verified.
Research focus
The group's test is whether a platform reduces the number of tools and data copies or becomes one more layer to govern. Commure sells ambient documentation, dictation, call centre agents, referral intake, revenue cycle and safety products, so ask which ones a reference customer actually runs and which were bought and shelved. Its regulatory paperwork is also region-specific: the Ambient AI product carries a Class I CE marking and a UK MHRA registration, and the company's own announcement of that does not mention the FDA.

Commure said on 19 May 2026 that it raised 70 million dollars at a 7 billion dollar post-money valuation, led by General Catalyst with Sequoia Capital, Morgan Stanley and Kirkland and Ellis taking part. No change of control was announced. Checked on 2026-10-10.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... Commure ... Company source

Commure's ambient notes tool gets a Class I CE marking and a UK registration

Commure said on 3 September 2026 that Commure Ambient AI received CE marking as a Class I medical device under EU MDR 2017/745 and was registered with the United Kingdom Medicines and Healthcare products Regulatory Agency under the Medical Devices Regulations 2002. The company says that under MDR Rule 11 the product qualifies as Class I because it drafts clinical documentation rather than informing diagnostic or therapeutic decisions, with clinicians reviewing and signing every note. The announcement does not mention the FDA.

Why it matters: The reason this is Class I and not something higher is that the tool is not allowed to influence a clinical decision, and that is a useful line for a buyer to hold the vendor to. If a future version starts suggesting a diagnosis or a treatment, it is a different risk class and a different submission, and a health system should ask to be told when that happens. The marking covers Europe and the United Kingdom only, so an American buyer gets nothing from it.

... Commure ... Company source

Commure launches Orchestrator to stop referrals falling through the cracks

Commure said on 30 June 2026 that it launched Orchestrator, a referral management and patient intake platform aimed at referral leakage. The company says it takes in unstructured referral data, pulls out the clinical and payer details, checks them against business rules, coordinates teams through one dashboard and writes accepted referrals into records systems, across inpatient, outpatient, post-acute, home health, hospice and specialty settings. Commure says it is already live with leading home health and ambulatory health systems and has processed hundreds of thousands of tasks fully autonomously, and quotes its president Dan Warner saying that every referral that does not convert is a patient who fell through the cracks.

Why it matters: Referral intake is still fax and phone work at most organisations, so there is real time to recover here, and writing the accepted referral into the records system is the part that decides whether staff keep using it. The announcement names no customer, which matters more than usual for a launch, because a platform that works in home health may behave very differently in a specialty clinic. A count of autonomous tasks is also not a conversion rate, and conversion is what referral leakage actually means.

... Commure ... Company source

Commure raises 70 million dollars at a 7 billion dollar valuation

Commure said on 19 May 2026 that it raised 70 million dollars at a 7 billion dollar post-money valuation, led by General Catalyst with Sequoia Capital, Morgan Stanley and Kirkland and Ellis also taking part. The company says the money goes into scaling its revenue cycle and practice management platform across specialty practices, hospitals and integrated delivery networks, into a shared intelligence layer for its agents covering payer rules, specialty coding and denial patterns, and into AI infrastructure for markets outside the United States. It says it operates inside more than 500 healthcare organisations across more than 3,000 sites of care, serves more than 130 of the largest health systems including HCA Healthcare and Tenet Healthcare, processes tens of billions of dollars of annual payments with more than 85 percent of the work completed without human intervention, and supports tens of millions of appointments a year through its ambient AI products.

Why it matters: Raising only 70 million dollars at a 7 billion dollar valuation is a small round against a large price, which usually means the company did not need the cash and was setting a marker rather than funding operations. The number a buyer should care about is the other one: more than 85 percent of revenue cycle work completed without a person, measured across tens of billions of dollars of payments. If that holds up in a specific contract it is the strongest claim in this group, and if it does not, it is the easiest to disprove. Naming HCA Healthcare and Tenet Healthcare is also a real commitment, because those organisations are large enough to be asked directly.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: The careers page showed no open positions at the time it was read, and describes engineering, product, operations, sales and clinical teams. It lists Mountain View in California as the headquarters, with offices in Utah, Los Angeles, New York and Brazil.

Qualification signal: This is a stack assembled from several products, so the useful experience is integration and change management inside a health system, not building one tool well. People who have retired a legacy system count more than people who have launched a new one.

Check current roles at Commure. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
CIO, chief data officer, chief AI officer, enterprise architecture, analytics, security, compliance, and service-line leadership
Primary use case
Create a shared data and workflow layer for healthcare AI applications, analytics, and automation
Typical deployment
Cloud platform connected to the EHR, data warehouse, payer or provider systems, and selected AI services

Evidence questions

  • Which production workflows run on the platform today and what result changed?
  • How much integration and data preparation remains the customer responsibility?
  • Can outcomes be separated by application rather than reported as one platform total?

Regulatory and workflow questions

  • How does the platform separate administrative automation from clinical decision support?
  • Can each model, agent, prompt, and data source be approved and monitored independently?
  • Who owns incident response when several vendors run through the same platform?

Data and contract questions

  • Where are source data copied, transformed, and retained?
  • What data and integration work is required when an application or model is replaced?
  • How are permissions, lineage, and customer-specific model training controlled?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

First-Hand Sources